Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
Acute Myeloid Leukemia Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 2,199.1 Million by 2028, exhibiting a growth rate (CAGR) of 12.7% during 2022-2028. Acute myeloid leukemia (AML) refers to a clonal malignancy leading to the rapid growth of abnormal cells. It ... Read More
-
Triple Negative Breast Cancer (TNBC) - Market Insight, Epidemiology And Market Forecast - 2032
... over the years. The most common and widely accepted classification of breast cancer is from an immunohistochemical perspective, based on the expression of the following hormone receptors: estrogen (ER), progesterone (PR), and human epidermal growth ... Read More
-
Metastatic Non-Small Cell Lung Cancer - Market Insight, Epidemiology and Market Forecast -2032
... NSCLC, continuous uptake of approved therapies mainly immune checkpoint inhibitors, expected entry of potential premium price emerging therapies and increasing awareness of mutations like KRAS, BRAF, c-Met and others. The total market size of metastatic ... Read More
-
Esophageal Squamous Cell Carcinoma Market Research Report Forecast till 2030
... research exercises and item endorsements, and rising public mindfulness are driving market development. The rising commonness of achalasia help market development because achalasia patients have a higher gamble of Esophageal Squamous Cell Carcinoma than everybody. ... Read More
-
Virtual Oncology Market, By Component (Software, Service, Hardware), By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, Bladder Cancer, Others (Pancreatic, Ovarian, etc.)), By Application (Precision Medicine, Patient Care Management, Research & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract Research Organizations (CROs), Others (Reference Laboratories, Pharmacies etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)
... & Development, Clinical Trials, Diagnosis & Treatment Decision Making, Data Management, Others (Billing Management, Regulatory Compliance etc.)), By End User (Hospitals & Diagnostic Imaging Centers, Academic Institutions & Research Centers, Pharma & Biotech Companies, Contract ... Read More
-
HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... and drug resistance mechanisms. In 2022, the United States accounted for the maximum share of the total market of HER2-positive breast cancer in the 7MM was around 60%. The approval of HERCEPTIN marked a turning ... Read More
-
Metastatic Prostate Cancer - Market Insight, Epidemiology And Market Forecast - 2032
... forecasted epidemiology as well as the metastatic prostate cancer market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan. The metastatic prostate cancer market report provides current ... Read More
-
Metastatic HR+/HER2− Breast Cancer - Market Insights, Epidemiology, and Market Forecast-2032
... breast cancer subtypes. The total market size in the 7MM for HR+/HER2- breast cancer was estimated to be USD 9,200 million in 2022, which is expected to grow by 2032. For the past decade, endocrine ... Read More
-
Non-metastatic Prostate Cancer (nmPC) - Market Insight, Epidemiology and Market Forecast -2032
... is a localized form of prostate cancer. When prostate cancer is diagnosed at this stage, it means that cancer cells are confined to the prostate and have not yet invaded surrounding tissues or metastasized (spread) ... Read More
-
T-Cell Lymphoma Market Report: Trends, Forecast and Competitive Analysis to 2030
... cell transplantation markets. The global T-cell lymphoma market is expected to reach an estimated $3.3 billion by 2030 with a CAGR of 6.5% from 2024 to 2030. The major drivers for this market are rising ... Read More
-
Cancer Immunotherapy Market, Size, Global Forecast 2024-2030, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis
... Research. Cancer immunotherapy is a cancer treatment that enhances the immune system's ability to fight cancer. This therapy is preferable to the old technique because it provides long-term cancer protection, has fewer side effects, and ... Read More
-
Cutaneous Bcell Lymphoma Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030
... the hospitals, and speciality clinics markets. The global cutaneous Bcell lymphoma treatment market is expected to grow with a CAGR of 2.3% from 2024 to 2030. The major drivers for this market are growing adoption ... Read More
-
Global Cancer Diagnostic Market - 2023-2030
... period 2023-2030. Molecular diagnostic techniques are rapidly used for cancer detection. It involves procedures for confirming specific types of cancer along with the tumor location, extent, and staging. Tissue biopsies are presently the gold standard ... Read More
-
Ewing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Ewing Sarcoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Ewing Sarcoma. Report includes an ... Read More
-
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
... Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical trials scenario. This report ... Read More
-
India Lymphedema Treatment Market Forecast (2020-2030), and Country Share, Trend, and Growth Opportunity Analysis Coverage: Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type [Compression Devices and Bandaging, Drug Therapy, Physiological Procedure (Lymphovenous Anastomosis and Vascularized Lymph Node Transfer), Debulking Procedure, and Others], and End User (Hospitals, Clinics, Clinical Research Organizations, and Others))
... Vascularized Lymph Node Transfer), Debulking Procedure, and Others], and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)) The India lymphedema treatment market size is projected to grow from US$ 0.926 billion in 2022 to ... Read More
-
Global Fentanyl Market Size study & Forecast, by Route of Administration (Sublingual Tablet, Buccal Tablet, Oral Film, and Others), by End User (Hospital, Oncology Centers, Surgical Centers, and Others) and Regional Analysis, 2023-2030
... Market is valued at approximately USD XX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. The market growth of cancer-related products ... Read More
-
Global Mammalian Cell Fermentation Technology Market Size Study & Forecast, by Type (Hamster Ovary (CHO) Cell Fermentation, Human Embryonic Kidney (HEK) Cell Fermentation, Baby Hamster Kidney (BHK) Cell Fermentation, Murine Myeloma Cell Fermentation, Others), By Application (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes and Others), By End-use (Biopharmaceutical Companies, CMOs & CDMOs, Academic & Research Institutes) and Regional Analysis, 2023-2030
... Application (Monoclonal Antibodies, Recombinant Proteins, Vaccines, Hormones, Enzymes and Others), By End-use (Biopharmaceutical Companies, CMOs & CDMOs, Academic & Research Institutes) and Regional Analysis, 2023-2030 Global Mammalian Cell Fermentation Technology Market is valued at approximately ... Read More
-
Canada Clinical Nutrition Market, By Nutrition Type (Enteral Nutrition (Standard Nutrition, Disease Specific Nutrition), Parenteral Nutrition (Amino Acid, Carbohydrates, Vitamins and Minerals, Others (Proteins, Lipids among Others))), By Form (Powder, Liquid, Tablets, Capsules, Gummies, Others (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases and Others)), By End User (Hospitals, Ambulatory Surgical Centers, Long Term Care Facilities)
... (Nutrition Bar, among Others)), By Route of Administration (Oral, Enteral, Parenteral), By Age Group (Infant Nutrition, Adult Nutrition, Geriatric Nutrition), By Application (Diabetes, Cancer, Critical Care, Neurological Disorder, Metabolic Syndrome, Gastrointestinal Diseases, Other (Cardiovascular Diseases ... Read More
-
US and Europe Metastases Spinal Tumor Market Research Report Forecast to 2030
... launch of the research start-up programme. However, the side effects associated with spine tumor treatments are anticipated to hamper the market growth. Metastatic spinal tumors are abnormal tissue clusters that can develop in the spine ... Read More
-
Global Cancer API Market Research Report - Forecast to 2030
... the projected period, the market share for cancer APIs is anticipated to experience significant growth. The development of molecular pharmaceuticals, the rising number of cancer cases, the trend toward offshore pharmaceutical producers, and the introduction ... Read More
-
2023 Neoplasms Global Market Size & Growth Report with COVID-19 & Recession Risk Impact
... (The Americas, Europe, Asia & Oceania, Africa & Middle East), 22 subregions, and 216 countries. Figures are from 2014 through 2022, with forecasts for 2023 and 2027. The historical data utilizes in-depth survey results from ... Read More
-
Multiple Myeloma Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... market to reach US$ 29.6 Billion by 2028, exhibiting a growth rate (CAGR) of 6.3% during 2023-2028. Multiple myeloma, or Kahler's disease, refers to a form of blood cancer that primarily affects the plasma cells. ... Read More
-
Cancer Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 53.7 Billion by 2028, exhibiting a growth rate (CAGR) of 12.95% during 2023-2028. Cancer biomarkers are biological molecules that indicate the presence of cancerous cells in the blood, tissues or other fluids of ... Read More
-
US Acute Myeloid Leukemia Market to 2028
... in Research and Development, and a constant growth in population. Advancement in therapeutic approaches, including targeted therapies, immunotherapies, checkpoint inhibitors, and personalized medicines, have revolutionized AML treatment, boosting patient satisfaction and reducing side effects. Rising ... Read More
Research Assistance
